Takehiko Kunimoto
About
In The Last Decade
Takehiko Kunimoto
37 papers receiving 827 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 550
- Oncology 393
- Cancer Research 88
- Pharmacology 86
- Pulmonary and Respiratory Medicine 81
Countries citing papers authored by Takehiko Kunimoto
This map shows the geographic impact of Takehiko Kunimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiko Kunimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiko Kunimoto more than expected).
Fields of papers citing papers by Takehiko Kunimoto
This network shows the impact of papers produced by Takehiko Kunimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiko Kunimoto. The network helps show where Takehiko Kunimoto may publish in the future.
Co-authorship network of co-authors of Takehiko Kunimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Takehiko Kunimoto. A scholar is included among the top collaborators of Takehiko Kunimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiko Kunimoto. Takehiko Kunimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Cancer screening literature in the period 2000-2002: pointers to future research avenues. | 3 |
| 3 | 11 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 72 | |
| 9 | 25 | |
| 10 | 18 | |
| 11 | 16 | |
| 12 | 30 | |
| 13 | Action of a new antibiotic, neo-enactin, on the cell membrane and its application to combination treatment in a cultured tumor cell system. | 6 |
| 14 | 12 | |
| 15 | Toxicity studies on jojoba oil for cosmetic uses [Toxicity tests on mice]. | 4 |
| 16 | Macromomycin, an inhibitor of the membrane function of tumor cells. | 27 |
| 17 | 12 | |
| 18 | 9 | |
| 19 | 15 | |
| 20 | Modes of action of phleomycin, bleomycin and formycin on HeLa S3 cells in synchronized culture. | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.